ES2067717T3 - Compuestos de acidos propano-fosfinicos p-sustituidos. - Google Patents
Compuestos de acidos propano-fosfinicos p-sustituidos.Info
- Publication number
- ES2067717T3 ES2067717T3 ES90810387T ES90810387T ES2067717T3 ES 2067717 T3 ES2067717 T3 ES 2067717T3 ES 90810387 T ES90810387 T ES 90810387T ES 90810387 T ES90810387 T ES 90810387T ES 2067717 T3 ES2067717 T3 ES 2067717T3
- Authority
- ES
- Spain
- Prior art keywords
- hydrogen
- hydroxy
- group
- aliphatic
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 239000002253 acid Substances 0.000 title 1
- 150000007513 acids Chemical class 0.000 title 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 6
- 239000001257 hydrogen Substances 0.000 abstract 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 3
- 125000001931 aliphatic group Chemical group 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical group 0.000 abstract 2
- 150000002431 hydrogen Chemical class 0.000 abstract 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 2
- 125000003277 amino group Chemical group 0.000 abstract 1
- 239000000935 antidepressant agent Substances 0.000 abstract 1
- 229940005513 antidepressants Drugs 0.000 abstract 1
- 239000002249 anxiolytic agent Substances 0.000 abstract 1
- 230000000949 anxiolytic effect Effects 0.000 abstract 1
- 229940005530 anxiolytics Drugs 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 239000000470 constituent Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 239000002664 nootropic agent Substances 0.000 abstract 1
- 230000001777 nootropic effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
- C07F9/36—Amides thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
- C07F9/301—Acyclic saturated acids which can have further substituents on alkyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Psychiatry (AREA)
- Neurology (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Cephalosporin Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Abstract
COMPUESTOS DE LA FORMULA I EN DONDE R1 ES HALOGENO, R1'' ES HALOGENO O HIDROGENO Y R2 Y R2'' DENOTAN HIDROGENO O R1 Y R1'' REPRESENTAN HIDROGENO, R2 ES UN RADICAL ALIFATICO O AROMATICO Y R2'' ES HIDROXILO O R2 Y R2'' REPRESENTAN JUNTOS OXO, Y EN DONDE R DENOTA UN RADICAL ALIFATICO, CICLOALIFATICO, CICLOALIFATICO-ALIFATICO O ARALIFATICO CON 2 O MAS ATOMOS DE CARBONO O, SI R1 Y R1'' DENOTAN HIDROGENO, R2 REPRESENTA UN RADICAL AROMATICO Y R2 ES HIDROXILO, R REPRESENTA METILO, Y SUS SALES RESULTAN UTILES COMO NOOTROPICOS, ANTIDEPRESIVOS Y/O ANSIOLITICOS. PUEDEN ELABORARSE MEDIANTE LA SUSTITUCION DE CUALQUIER GRUPO R5 POR HIDROGENO Y/O LA CONVERSION DE CUALQUIER GRUPO Z0 EN AMINO EN UN COMPUESTO DE LA FORMULA II EN DONDE R, R1, R1'', R2 Y R2'' TIENEN SUS SIGNIFICACIONES PREVIAS, Z REPRESENTA UN GRUPO AMINO PROTEGIDO O LATENTE ZO Y R4 DENOTA HIDROGENO O UN GRUPO HIDROXILO-PROTECTOR R5, Y EN DONDE AMINO COMO CONSTITUYENTE DE R Y/O HIDROXILO R2'' U OXO + R2'' PUEDEN ESTAR PRESENTES EN FORMA PROTEGIDA TEMPORALMENTE.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB898912814A GB8912814D0 (en) | 1989-06-03 | 1989-06-03 | P-substituted propane-phospinic acid compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2067717T3 true ES2067717T3 (es) | 1995-04-01 |
Family
ID=10657847
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES90810387T Expired - Lifetime ES2067717T3 (es) | 1989-06-03 | 1990-05-25 | Compuestos de acidos propano-fosfinicos p-sustituidos. |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP0402312B1 (es) |
| JP (1) | JPH0320288A (es) |
| KR (1) | KR910000766A (es) |
| AT (1) | ATE117693T1 (es) |
| AU (1) | AU633577B2 (es) |
| CA (1) | CA2018036A1 (es) |
| DD (1) | DD294945A5 (es) |
| DE (1) | DE69016270T2 (es) |
| DK (1) | DK0402312T3 (es) |
| ES (1) | ES2067717T3 (es) |
| FI (1) | FI95263C (es) |
| GB (1) | GB8912814D0 (es) |
| HU (1) | HU207335B (es) |
| IE (1) | IE65155B1 (es) |
| IL (1) | IL94537A (es) |
| MX (1) | MX20962A (es) |
| NO (1) | NO177675C (es) |
| NZ (1) | NZ233915A (es) |
| PT (1) | PT94244B (es) |
| YU (1) | YU106890A (es) |
| ZA (1) | ZA904203B (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8728483D0 (en) * | 1987-12-04 | 1988-01-13 | Ciba Geigy Ag | Chemical compounds |
| EP0543780A3 (en) * | 1991-11-21 | 1993-09-01 | Ciba-Geigy Ag | Novel aminoalkanephosphinic acids and their salts |
| DE19604195C1 (de) * | 1996-02-06 | 1997-04-17 | Hoechst Ag | Verfahren zur Herstellung von Phosphonigsäuremonoalkylestern |
| CN1309659A (zh) | 1998-07-15 | 2001-08-22 | 哈桑·朱马 | 有机磷化合物及其用途 |
| SE0102055D0 (sv) * | 2001-06-08 | 2001-06-08 | Astrazeneca Ab | New Compounds |
| DE102008056341A1 (de) * | 2008-11-07 | 2010-05-12 | Clariant International Limited | Verfahren zur Herstellung von monoaminofunktionalisierten Dialkylphosphinsäuren, -estern und -salzen mittels Acrylnitrilen und ihre Verwendung |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2032712C3 (de) * | 1970-07-02 | 1978-10-19 | Bayer Ag, 5090 Leverkusen | Verfahren zur Herstellung von w-Amino-alkanphosphonsäure bzw.- phosphinsäurederivaten |
| GB8728483D0 (en) * | 1987-12-04 | 1988-01-13 | Ciba Geigy Ag | Chemical compounds |
| GB8820266D0 (en) * | 1988-08-26 | 1988-09-28 | Smith Kline French Lab | Compounds |
-
1989
- 1989-06-03 GB GB898912814A patent/GB8912814D0/en active Pending
-
1990
- 1990-05-25 ES ES90810387T patent/ES2067717T3/es not_active Expired - Lifetime
- 1990-05-25 DK DK90810387.2T patent/DK0402312T3/da active
- 1990-05-25 EP EP90810387A patent/EP0402312B1/en not_active Expired - Lifetime
- 1990-05-25 DE DE69016270T patent/DE69016270T2/de not_active Expired - Fee Related
- 1990-05-25 AT AT90810387T patent/ATE117693T1/de active
- 1990-05-28 IL IL9453790A patent/IL94537A/en unknown
- 1990-05-31 DD DD90341208A patent/DD294945A5/de not_active IP Right Cessation
- 1990-05-31 MX MX2096290A patent/MX20962A/es unknown
- 1990-05-31 AU AU56161/90A patent/AU633577B2/en not_active Ceased
- 1990-05-31 YU YU106890A patent/YU106890A/sh unknown
- 1990-06-01 HU HU903299A patent/HU207335B/hu not_active IP Right Cessation
- 1990-06-01 NZ NZ233915A patent/NZ233915A/en unknown
- 1990-06-01 NO NO902449A patent/NO177675C/no unknown
- 1990-06-01 IE IE198090A patent/IE65155B1/en not_active IP Right Cessation
- 1990-06-01 ZA ZA904203A patent/ZA904203B/xx unknown
- 1990-06-01 CA CA002018036A patent/CA2018036A1/en not_active Abandoned
- 1990-06-01 FI FI902749A patent/FI95263C/fi not_active IP Right Cessation
- 1990-06-01 PT PT94244A patent/PT94244B/pt not_active IP Right Cessation
- 1990-06-02 KR KR1019900008137A patent/KR910000766A/ko not_active Ceased
- 1990-06-04 JP JP2144591A patent/JPH0320288A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| IE901980L (en) | 1990-12-03 |
| NO177675C (no) | 1995-11-01 |
| GB8912814D0 (en) | 1989-07-19 |
| MX20962A (es) | 1994-02-28 |
| CA2018036A1 (en) | 1990-12-03 |
| EP0402312A2 (en) | 1990-12-12 |
| HU207335B (en) | 1993-03-29 |
| KR910000766A (ko) | 1991-01-30 |
| JPH0320288A (ja) | 1991-01-29 |
| NO902449D0 (no) | 1990-06-01 |
| ATE117693T1 (de) | 1995-02-15 |
| FI95263B (fi) | 1995-09-29 |
| PT94244B (pt) | 1997-03-31 |
| DE69016270D1 (de) | 1995-03-09 |
| FI95263C (fi) | 1996-01-10 |
| IL94537A0 (en) | 1991-03-10 |
| HUT54169A (en) | 1991-01-28 |
| NZ233915A (en) | 1992-07-28 |
| DD294945A5 (de) | 1991-10-17 |
| IE65155B1 (en) | 1995-10-04 |
| FI902749A0 (fi) | 1990-06-01 |
| EP0402312B1 (en) | 1995-01-25 |
| IL94537A (en) | 1994-11-28 |
| YU106890A (sh) | 1992-07-20 |
| PT94244A (pt) | 1991-02-08 |
| DK0402312T3 (da) | 1995-02-27 |
| EP0402312A3 (en) | 1991-04-03 |
| AU633577B2 (en) | 1993-02-04 |
| AU5616190A (en) | 1990-12-06 |
| DE69016270T2 (de) | 1995-06-08 |
| NO902449L (no) | 1990-12-04 |
| ZA904203B (en) | 1991-02-27 |
| NO177675B (no) | 1995-07-24 |
| HU903299D0 (en) | 1990-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| YU218788A (en) | Process for preparing substituted propan-phosphinic acids | |
| DE3372364D1 (en) | 1-carboxyalkanoylperhydroindole-2-carboxylic acids and derivatives | |
| PH30222A (en) | N-aralkyl-and n-hetero-aralkyl-aminoalkane phosphinic acids | |
| DE69016270D1 (de) | P-substituierte Propanphosphinsäureverbindungen. | |
| LTIP704A (en) | Process for the preparation of hexahydroazepines derivatives | |
| GR3034023T3 (en) | Phenyl carboxamide-isoxazole-derivatives and salts, process for their preparation, their use as pharmaceuticals, and pharmaceutical compositions containing them. | |
| ES8303279A1 (es) | "procedimiento para preparar nuevos derivados de acidos fenil-alifatico-carboxilicos". | |
| EP0141200A3 (en) | Dihydroxyalkanediphosphonic acids | |
| GR3022546T3 (en) | Inositol phosphate analogues as calcium-antagonistic substances | |
| AU572888B2 (en) | 4-(3-alkynyloxy-2-hydroxy-propyl)-piperazin-i-yl-n- phenyl-acetamide derivatives | |
| NO963791L (no) | Peptidderivater | |
| DE3587915D1 (de) | Verfahren zur Herstellung von Cephalosporinen. | |
| ECSP951403A (es) | Compuestos heterociclicos y fenilo | |
| AR247567A1 (es) | Procedimiento para preparar carbonitrilos azatetraciclicos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 402312 Country of ref document: ES |